Major domestic pharmaceutical firms eye 18.7% growth in turnover

Published: 2003-02-10 07:00:00

Updated: 2003-02-10 07:00:00

The 23 major domestic pharmaceutical firms set their turnover growth rate this year at 18.7 percent on average (combined turnover: 4.1 trillion won) compared with 3.5 trillion won (estimated), according to the analyses on 2003 management strategies of chief executives officers of major drug manuf...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK